Hyung-Sik Kim

33PUBLICATIONS
40CO-AUTHORS
ChemotherapyGene and molecular therapyMolecular targetsMedical molecular engineering of nucleic acids and proteinsTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 13, 2026
PKM2 Inhibitors Induce Autophagic Cell Death Through Suppression of PKM2-Mediated Glycolysis in Cisplatin-Resistant Ovarian Cancer Cells.

|Feb 17, 2026
A Novel Peptide, HS1002, Enhances Antitumor Activity via Dual Targeting of the GnRH Receptor and Human Telomerase Reverse Transcriptase in Prostate Cancer Cells.

Jae Hyeon Park, Joo Chan Lee, Swati Sharma

|Nov 27, 2025
BKS-112, a Selective Histone Deacetylase 6 Inhibitor, Suppresses Triple-Negative Breast Cancer Cells via AKT/mTOR Pathway.

Sreevarsha Gali, Swati Sharma, Hyunji Noh

|Jul 27, 2024
The Cell-Penetrating Peptide GV1001 Enhances Bone Formation via Pin1-Mediated Augmentation of Runx2 and Osterix Stability.

Meiyu Piao, Sung Ho Lee, Jin Wook Hwang

|May 25, 2024
Exploring the Metabolic Effects of a Herbal Remedy of Asarum sieboldii, Platycodon grandiflorum, and Cinnamomum cassia Extracts: Unraveling Its Therapeutic Potential as a Topical Application for Atopic Dermatitis Treatment.

Gakyung Lee, Byung Hwa Jung, Taemin Lee

|May 13, 2023
First-Line Combination Treatment with Low-Dose Bipolar Drugs for ABCB1-Overexpressing Drug-Resistant Cancer Populations.

Sungpil Yoon, Hyung Sik Kim

Pageof 6

Frequent Collaborators

4 joint publications

In Su Kim

4 joint publications

Sungpil Yoon

2 joint publications

Sreevarsha Gali

2 joint publications

Seung-Cheol Jee